492 related articles for article (PubMed ID: 25132741)
1. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I
World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma.
Li W; Li M; Liao D; Lu X; Gu X; Zhang Q; Zhang Z; Li H
Oncotarget; 2016 Aug; 7(34):55110-55127. PubMed ID: 27391153
[TBL] [Abstract][Full Text] [Related]
3. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
Bai PS; Xia N; Sun H; Kong Y
J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review.
Sivasudhan E; Blake N; Lu Z; Meng J; Rong R
Cells; 2022 Feb; 11(4):. PubMed ID: 35203390
[TBL] [Abstract][Full Text] [Related]
5. Modulation of apoptotic signaling by the hepatitis B virus X protein.
Rawat S; Clippinger AJ; Bouchard MJ
Viruses; 2012 Nov; 4(11):2945-72. PubMed ID: 23202511
[TBL] [Abstract][Full Text] [Related]
6. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
Gouas DA; Villar S; Ortiz-Cuaran S; Legros P; Ferro G; Kirk GD; Lesi OA; Mendy M; Bah E; Friesen MD; Groopman J; Chemin I; Hainaut P
Carcinogenesis; 2012 Jun; 33(6):1219-24. PubMed ID: 22759751
[TBL] [Abstract][Full Text] [Related]
7. HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation.
Niu LJ; Huang T; Wang L; Sun XF; Zhang YM
Ann Hepatol; 2022; 27(3):100688. PubMed ID: 35196550
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression.
Lim JH; Kim DG; Yu DY; Kang HM; Noh KH; Kim DS; Park D; Chang TK; Im DS; Jung CR
Cell Mol Life Sci; 2019 Jul; 76(13):2647-2662. PubMed ID: 30903204
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma and the underlying mechanisms.
Oyagbemi AA; Azeez OI; Saba AB
Afr Health Sci; 2010 Mar; 10(1):93-8. PubMed ID: 20811532
[TBL] [Abstract][Full Text] [Related]
10. Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis.
Schollmeier A; Glitscher M; Hildt E
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902395
[TBL] [Abstract][Full Text] [Related]
11. Fusion HBx from HBV integrant affects hepatocarcinogenesis through deregulation of ER stress response.
Muroyama R; Nakagawa R; Matsubara Y; Hirata Y; Omata M; Shirasawa H; Kato N
Virus Res; 2022 Jul; 315():198787. PubMed ID: 35430320
[TBL] [Abstract][Full Text] [Related]
12. HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells.
Zhu M; Guo J; Li W; Xia H; Lu Y; Dong X; Chen Y; Xie X; Fu S; Li M
BMC Cancer; 2015 May; 15():362. PubMed ID: 25943101
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell death.
Huang FY; Wong DK; Mak LY; Cheung TT; Seto WK; Yuen MF
Carcinogenesis; 2022 Aug; 43(7):671-681. PubMed ID: 35353897
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma.
Yang L; Zou T; Chen Y; Zhao Y; Wu X; Li M; Du F; Chen Y; Xiao Z; Shen J
Hepatol Int; 2022 Aug; 16(4):741-754. PubMed ID: 35648301
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus X Protein Modulates p90 Ribosomal S6 Kinase 2 by ERK to Promote Growth of Hepatoma Cells.
Han N; Zhang Q; Tang X; Bai L; Yan L; Tang H
Viruses; 2023 May; 15(5):. PubMed ID: 37243268
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro.
Wu G; Yu F; Xiao Z; Xu K; Xu J; Tang W; Wang J; Song E
Br J Cancer; 2011 Jun; 105(1):146-53. PubMed ID: 21629246
[TBL] [Abstract][Full Text] [Related]
17. HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function.
Liu N; Zhang J; Yang X; Jiao T; Zhao X; Li W; Zhu J; Yang P; Jin J; Peng J; Li Z; Ye X
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592528
[TBL] [Abstract][Full Text] [Related]
18. Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer.
Chaomin W; Wenhao N; Jialei H; Ting Z; Honglei F; Zhuang H; Yichao W; Changsen B; Yueguo L
Cell Oncol (Dordr); 2022 Aug; 45(4):573-589. PubMed ID: 35716259
[TBL] [Abstract][Full Text] [Related]
19. HBx increases chromatin accessibility and ETV4 expression to regulate dishevelled-2 and promote HCC progression.
Zheng C; Liu M; Ge Y; Qian Y; Fan H
Cell Death Dis; 2022 Feb; 13(2):116. PubMed ID: 35121725
[TBL] [Abstract][Full Text] [Related]
20. Chemical shift assignments of a fusion protein comprising the C-terminal-deleted hepatitis B virus X protein BH3-like motif peptide and Bcl-x
Kusunoki H; Hamaguchi I; Kobayashi N; Nagata T
Biomol NMR Assign; 2022 Oct; 16(2):357-361. PubMed ID: 36044106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
